Gastrointestinal Therapeutics

SHERIDAN, WYOMING, UNITED STATES, April 13, 2023 /EINPresswire.com/ -- According to the latest report by IMARC Group, titled “Gastrointestinal Therapeutics Market: Global Industry Trends, Size, Share, Growth, Opportunity and Forecast 2023-2028“, The global gastrointestinal therapeutics market size reached US$ 44.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 59.6 Billion by 2028, exhibiting a growth rate (CAGR) of 4.9% during 2023-2028.

Gastrointestinal Therapeutics Market Overview:

Gastrointestinal (GI) therapeutics are medications used to treat various digestive system disorders, including the stomach, intestines, liver, and pancreas. These medications are designed to alleviate symptoms such as nausea, vomiting, diarrhea, constipation, and abdominal pain and to treat underlying conditions such as gastroesophageal reflux disease (GERD), inflammatory bowel disease (IBD), and liver disease. GI therapeutics include many drugs, including proton pump inhibitors (PPIs), H2 receptor antagonists, antacids, laxatives, and anti-diarrheal agents. These medications are administered orally, rectally, or intravenously and are often combined with lifestyle changes such as dietary modifications and stress reduction techniques to manage GI conditions effectively.

Request Free Sample Report: https://www.imarcgroup.com/gastrointestinal-therapeutics-market/requestsample

Gastrointestinal Therapeutics Market Demand Analysis:

The global market is primarily driven by the increasing prevalence of gastrointestinal diseases, such as inflammatory bowel disease, gastroesophageal reflux disease, and irritable bowel syndrome. In line with this, the expanding geriatric population and the growing demand for effective treatments are significantly contributing to the market. Furthermore, the advancements in drug delivery systems and the launch of new and innovative drugs are expected to catalyze the market. Apart from this, the escalating demand for biologics and targeted therapies for gastrointestinal disorders is positively influencing the market. Growing awareness of gastrointestinal disorders and their impact on quality of life is accelerating GI therapeutics demand worldwide. Moreover, the increasing healthcare expenditure and investments in research and development of new drugs are propelling the market. Developing combination therapies that target multiple pathways in treating gastrointestinal disorders is creating a positive outlook for the market. Besides, the rapid adoption of minimally invasive surgical procedures for gastrointestinal disorders is strengthening the market. The easy availability of over-the-counter gastrointestinal therapeutics for treating common gastrointestinal symptoms such as heartburn, indigestion, and constipation is anticipated to boost the market.

Ask Analyst and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/gastrointestinal-therapeutics-market

Key Market Segmentation:

Breakup by Type:

• Branded
• Generic

Breakup by Route of Administration:

• Oral
• Intravenous
• Others

Breakup by Application:

• Ulcerative Colitis
• Crohn's Disease
• GERD
• Others

Breakup by Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Browse More Research Reports:

• https://www.openpr.com/news/2941946/largest-geosynthetics-suppliers-worldwide-by-imarc-group
• https://www.openpr.com/news/2941909/best-fertilizer-brands-in-india-by-imarc-group
• https://www.openpr.com/news/2941962/list-of-best-head-up-display-brands-worldwide-by-imarc-group
• https://www.openpr.com/news/2941979/leading-bakery-ingredients-brands-in-world-by-imarc-group
• https://www.openpr.com/news/2941897/leading-lithium-ion-battery-brands-worldwide-by-imarc-group

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Elena Anderson
IMARC Services Private Limited
+1 631-791-1145
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.